Dinuclear Cu2+-complexes disrupt cellular pathways and rewire the breast cancer proteome
Journal of Proteomics · 2026
DOI: 10.1016/j.jprot.2025.105570 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Proteomics, 2026. Verfasst von Zeinab Ghasemishahrestani und 9 weiteren Autor:innen. Beteiligte Einrichtung: Departamento de Bioquímica, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Departamento de Microbiologia G…. Hauptthemen laut MEDLINE: Copper, Breast Neoplasms, Proteome, Antineoplastic Agents. Die Arbeit nennt 70 Literaturangaben. Gefördert von: Coordenação de Aperfeiçoamento de Pessoal de Nível Superior, Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State, Conselho Nacional de Desenvolvimento Científico e Tecnológico.
Abstract (Originalsprache)
Cancer's global burden highlights the urgent need for more effective therapies. Metal-based drugs, particularly Cu2-complexes, offer promising alternatives due to copper's diverse biological functions. This study investigates the antitumor potential of two novel dinuclear Cu2-complexes, [Cu2(μ-CH3COO)(L)(OH2)]·2H2O (R9) and [Cu2(μ-OH)(HL)(OH2)]ClO4·2H2O (R10), in MCF-7 breast cancer cells. Both compounds exhibited greater cytotoxicity than cisplatin, with IC50 values of 1.01 ± 0.09 μM (R9) and 1.27 ± 0.14 μM (R10), while showing selectivity toward cancer cells, as indicated by higher IC50 values in healthy MCF10A cells. Treated MCF-7 cells showed increased granularity, mitochondrial membrane depolarization, and elevated reactive oxygen species. At IC50 concentrations, cell cycle analysis revealed Sub-G1 accumulation and DNA fragmentation (TUNEL assay), indicating apoptosis via intrinsic pathways, supported by caspase 9 activation. Label-free proteomics revealed distinct mechanisms for R10 compared to cisplatin. In R10-treated cells, key downregulated pathways included glycolysis, the TCA cycle, oxidative phosphorylation, PI3K-Akt signaling, and the ubiquitin-proteasome system. Apoptosis-related proteins such as structural proteins (ACTB, ACTG1, SPTAN1, TUBA4A), mitochondrial apoptotic factors (AIFM1), nuclear envelope components (LMNA), and stress-response regulators (JUN, EIF2S1) were dysregulated. Proteomics data is available via ProteomeXchange with identifier PXD064464. These findings support the potential of Cu2-complexes as effective antitumor agents with mechanisms distinct from cisplatin, offering superior efficacy through apoptosis induction. SIGNIFICANCE: Breast cancer remains one of the leading causes of cancer-related mortality among women, highlighting the need for more effective and selective therapeutic agents. While platinum-based drugs are widely used, their limitations call for novel alternatives. In this study, we demonstrate that two newly synthesized dinuclear copper(II) complexes, R9 and R10, exhibit strong cytotoxicity against MCF-7 breast cancer cells with higher selectivity compared to cisplatin. Through functional and proteomic analyses, we show that these compounds induce intrinsic apoptosis, disrupt cytoskeletal integrity, and modulate key signaling pathways such as PI3K-Akt and RAS-ERK. Our proteomic results reveal distinct molecular signatures for R10, underscoring its unique mechanism of action. Therefore, copper-based complexes represent promising candidates for breast cancer treatment, and proteomics provides critical insight into their therapeutic potential.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Departamento de Bioquímica, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil; Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Federal d…
- Departamento de Microbiologia Geral, Instituto de Microbiologia Paulo de Góes, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil.
- LABSO-Bio, Department of Chemistry, Pontifical Catholic University of Rio de Janeiro, 22453-900 Rio de Janeiro, RJ, Brazil.
- Proteomics Unit, Department of Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, 21941-909 Rio de Janeiro, RJ, Brazil.
- Proteomics Unit, Department of Biochemistry, Institute of Chemistry, Federal University of Rio de Janeiro, Rio de Janeiro, 21941-909 Rio de Janeiro, RJ, Brazil; Laboratory of Proteomics, LADETEC, Institute of Chemistry,…
- Departamento de Bioquímica, Instituto de Química, Universidade Federal do Rio de Janeiro, Rio de Janeiro, RJ, Brazil. Electronic address: marcosdp@iq.ufrj.br.
Förderung
- Coordenação de Aperfeiçoamento de Pessoal de Nível Superior
- Carlos Chagas Filho Foundation for Research Support of Rio de Janeiro State
- Conselho Nacional de Desenvolvimento Científico e Tecnológico
Zitieren
APA
Ghasemishahrestani, Z., de Oliveira, S. S. C., Dos Santos Moraes Francisco, R., Ramos, L. F. C., Dos Santos, R. M., Domont, G. B., Rey, N. A., Dos Santos, A. L. S., Nogueira, F. C. S., & Pereira, M. D. (2026). Dinuclear Cu2+-complexes disrupt cellular pathways and rewire the breast cancer proteome. Journal of Proteomics. https://doi.org/10.1016/j.jprot.2025.105570
Vancouver
Ghasemishahrestani Z, de Oliveira SSC, Dos Santos Moraes Francisco R, Ramos LFC, Dos Santos RM, Domont GB, et al. Dinuclear Cu2+-complexes disrupt cellular pathways and rewire the breast cancer proteome. Journal of Proteomics. 2026. doi:10.1016/j.jprot.2025.105570
BibTeX
@article{Ghasemishahrestani2026,
author = {Ghasemishahrestani, Zeinab and de Oliveira, Simone Santiago Carvalho and Dos Santos Moraes Francisco, Rafaela and Ramos, Luis Felipe Costa and Dos Santos, Renata Maria and Domont, Gilberto Barbosa and Rey, Nicolás A and Dos Santos, André Luis Souza and Nogueira, Fabio Cesar Sousa and Pereira, Marcos Dias},
title = {Dinuclear Cu2+-complexes disrupt cellular pathways and rewire the breast cancer proteome},
journal = {Journal of Proteomics},
year = {2026},
doi = {10.1016/j.jprot.2025.105570}
}
EUVIMED